At the upcoming 2017 North American Spine Society annual meeting, four physicians will present on the efficacy of Zimmer Biomet's Mobi-C Cervical Disc.
Here are five things to know:
1. The four physicians presenting their clinical studies include:
• Tierry Dufour, MD, of Spine Center of Paris, France
• Kris Radcliff, MD, of Rothman Institute, Egg Harbor, N.J.
• Hyun Bae, MD, of Los Angeles-based Cedars Sinai Medical Center
• Pierce Nunley, MD, of Louisiana Spine Institute, Shreveport
2. The Mobi-C Cervical Disc is the first cervical disc prosthesis approved by the FDA for reconstruction of the cervical disc at both one and two levels to treat neck pain and spine
disorders.
3. The cervical disc is mobile-bearing and inserted in a single step without requiring bone chiseling to accommodate vertebral anchorage, such as crews or keels. Mobi-C is designed to be
implanted using an anterior approach.
4. Additionally, Zimmer Biomet Spine will feature its newly launched Vitality+ and Vital Spinal Fixation System at the North American Spine Society annual meeting.
5. Zimmer Biomet General Manager of Global Spine Joe Ross said, "In addition, we are honored that our Mobi-C presentation on the clinical implications of heterotopic ossification after
seven years received the NASS Section on Spine Motion Technology Best Paper Rating."